Evidence map›Paper›PMID 33707443›Full record

ArticleNPJ vaccines2021

Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques.

Nichole R Klatt, Courtney Broedlow, Jessica M Osborn, Andrew T Gustin, Sandra Dross, Megan A O'Connor, Ernesto Coronado, Philip Barnette, Tiffany Hensley-McBain, Alexander S Zevin and 12 more

Open access · goldAbstract read
In one paragraph

Article in NPJ vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Review
  6. Review
  7. Microbiome Studies in Non-human Primates.Current HIV/AIDS reports · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Nichole R KlattDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA. klat0037@umn.edu.ORCID http://orcid.org/0000-0003-2968-5480
Courtney BroedlowDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.
Jessica M OsbornWashington National Primate Research Center, University of Washington, Seattle, WA, USA.
Andrew T GustinDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-8760-8320
Sandra DrossWashington National Primate Research Center, University of Washington, Seattle, WA, USA.
Megan A O'ConnorWashington National Primate Research Center, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-2127-5073
Ernesto CoronadoDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.
Philip BarnetteOregon National Primate Research Center, Oregon Health and Science University, Portland, OR, USA.
Tiffany Hensley-McBainDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.
Alexander S ZevinDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.
Roshell MuirDivision of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA, USA.
Alexander RoedererDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-6168-0527
Solomon WangariWashington National Primate Research Center, University of Washington, Seattle, WA, USA.
Naoto IwayamaWashington National Primate Research Center, University of Washington, Seattle, WA, USA.
Chul Y AhrensWashington National Primate Research Center, University of Washington, Seattle, WA, USA.
Jeremy SmedleyWashington National Primate Research Center, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-3369-4662
Cassandra MoatsWashington National Primate Research Center, University of Washington, Seattle, WA, USA.
Rebecca M LynchDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.ORCID http://orcid.org/0000-0002-7188-8073
Elias K HaddadDivision of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA, USA.
Nancy L HaigwoodOregon National Primate Research Center, Oregon Health and Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-1477-9575
Deborah H FullerWashington National Primate Research Center, University of Washington, Seattle, WA, USA.
Jennifer A ManuzakDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA. jmanuzak@tulane.edu.ORCID http://orcid.org/0000-0002-0079-2306
University of Washington · USOregon National Primate Research Center · USDrexel University · USUniversity of Minnesota · USGeorge Washington University · USTulane University · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Persistent modulation of microbiota to enhance HIV vaccinationR01AI120712 · NIAID · UNIVERSITY OF WASHINGTON · PI KLATT, NICHOLE ROSE · 2015 to 2019
$4.0M
Impact of Malaria Co-Infection on HIV VaccinationK01OD024876 · OD · UNIVERSITY OF WASHINGTON · PI MANUZAK, JENNIFER · 2017 to 2019
$1.0M
NIAID NIH HHS R01 AI120712NIAID NIH HHS T32 AI007140NIAID NIH HHS T32 AI007509NIH HHS K01 OD024876NIH HHS P51 OD010425NIH HHS P51 OD011092NIH HHS P51 OD011104U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI120712U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) K01OD024876
6 · The paper itself

Abstract

An effective vaccine to prevent HIV transmission has not yet been achieved. Modulation of the microbiome via probiotic therapy has been suggested to result in enhanced mucosal immunity. Here, we evaluated whether probiotic therapy could improve the immunogenicity and protective efficacy of SIV/HIV vaccination. Rhesus macaques were co-immunized with an SIV/HIV DNA vaccine via particle-mediated epidermal delivery and an HIV protein vaccine administered intramuscularly with Adjuplex™ adjuvant, while receiving daily oral Visbiome

Identifiers

PMID33707443
PMCPMC7952719
OpenAlexW3133726766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.